生脉注射液联合重组人脑利钠肽和呋塞米 治疗老年急性心力衰竭的效果

打开文本图片集

[Abstract] Objective：To observe the efect Shengmai Injection combined with Recombinant Human Brain Natriuretic PeptideandFurosemidein the treatment elderlyacute heart failure.Method： FromJune 2022 to June 2O24，8O elderlypatients with acute heart failure admited to Guangdong Cliffrd Hospital were randomly divided into two groups using the random envelope method.Both groups received routine treatment，and on this basis，the control group （4O cases）was treated with Recombinant Human Brain Natriuretic Peptide and Furosemide， while theobservationgroup （4O cases）was additional treated withShengmai Injection.Theclinical eficacy the two groups was compared.Result： The clinical eficacy，MAP，6-minute walking test （6MWT） distance，left ventricular ejection fraction （LVEF），and cardiac output （CO） the observation group were higher than those the control group，the traditional Chinese medicine syndrome score，brain natriuretic peptide （BNP），resting HR，left ventricular end-systolic diameter （LVESD），and left ventricular end-diastolic diameter （LVEDD） the observation group were better than those the control group （ P- <0.05）.There was no statistically significant difference in adverse reactions between the two groups（ P>0.05 ）.Conclusion：The combination Shengmai Injection，Recombinant Human Brain Natriuretic Peptide，andFurosemide in the treatment elderly patientswith acute heart failure can improve heart failure symptoms，and further improve their cardiac function.

[Keywords]Shengmai InjectionRecombinant Human Brain Natriuretic PeptideFurosemideElderly Acuteheartfailure Heartfunction

First-author's address： Department Emergency， Guangdong Cliford Hospital， Guangzhou 511495，

doi：10.3969/j.issn.1674-4985.2025.21.014

急性心力衰竭是指由于急性严重心肌损伤、心律失常等影响导致患者短时间内出现心功能衰竭或慢性心力衰竭急剧恶化的临床综合征。（剩余6025字）